Wilfred A. Jefferies
Founder at MYND LIFE SCIENCES INC.
Net worth: 217 152 $ as of Today
Profile
Wilfred A.
Jefferies is the founder of Nevis Brands, Inc. (founded in 2011) and MYND Life Sciences, Inc. (founded in 2018) where he holds the title of Chief Science Officer.
Dr. Jefferies is also the founder of Synapse Technologies, Inc., Eyam Vaccines & Immunotherapeutics Ltd...
Dr. Jefferies's current job(s) include Chairman & Chief Scientific Officer at CAVA Healthcare, Inc., and Professor at the University of British Columbia and Michael Smith Laboratories.
Dr. Jefferies's former job includes Chairman & Chief Scientific Officer at Marker Therapeutics, Inc. Dr. Jefferies's education history includes an undergraduate degree from the University of Victoria and a doctorate degree from the Sir William Dunn School of Pathology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MYND LIFE SCIENCES INC
21.63% | 2023-02-01 | 10,340,583 ( 21.63% ) | 217 152 $ | 2024-03-30 |
inf% | 2023-10-17 | 9,176,683 ( inf% ) | - $ | Today |
Wilfred A. Jefferies active positions
| Companies | Position | Start |
|---|---|---|
| MYND LIFE SCIENCES INC. | Founder | 2018-07-05 |
| University of British Columbia | Corporate Officer/Principal | - |
Michael Smith Laboratories
 Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
CAVA Healthcare, Inc.
 CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Chairman | - |
| Eyam Vaccines & Immunotherapeutics Ltd. | Founder | - |
Former positions of Wilfred A. Jefferies
| Companies | Position | End |
|---|---|---|
| NEVIS BRANDS INC. | Founder | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Founder | - |
| MARKER THERAPEUTICS, INC. | Chairman | 2009-08-30 |
Training of Wilfred A. Jefferies
| University of Victoria | Undergraduate Degree |
| Sir William Dunn School of Pathology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| MYND LIFE SCIENCES INC. | Health Technology |
| Private companies | 4 |
|---|---|
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Commercial Services |
| Eyam Vaccines & Immunotherapeutics Ltd. |
- Stock Market
- Insiders
- Wilfred A. Jefferies
